Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Published:2016-03 Issue:3 Volume:94 Page:580-587
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Brade Anthony M.,Ng Sylvia,Brierley James,Kim John,Dinniwell Robert,Ringash Jolie,Wong Rebecca R.,Cho Charles,Knox Jennifer,Dawson Laura A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference17 articles.

1. International trends in liver cancer incidence rates;Center;Cancer Epidemiol Biomarkers Prev,2011

2. Cancer Statistics, 2014;Siegel;CA Cancer J Clin,2014

3. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma;Bujold;J Clin Oncol,2013

4. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma;Cardenes;Clin Transl Oncol,2010

5. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: Preliminary analysis;Choi;BMC Cancer,2008

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interpretation of the updates of the chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition);Hepatoma Research;2024-07-17

2. Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review;Chinese Clinical Oncology;2024-06

3. Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model;International Journal of Molecular Sciences;2024-02-02

4. Stereotactic body radiation therapy for liver metastases in oligometastatic disease;Cancer/Radiothérapie;2024-02

5. Hepatobiliary Malignancies;Hypofractionated and Stereotactic Radiation Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3